| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8714962 | Journal of the American Academy of Dermatology | 2018 | 25 Pages |
Abstract
Subsequent NMSCs are very frequent in LTRs, and conversion from a calcineurin inhibitor-based immunosuppressive regimen to a mammalian target of rapamycin inhibitor/antimetabolite-based immunosuppressive regimen can reduce subsequent NMSCs.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Pamela MD, Emilie MD, Olivier MD, José MD, Evelyne PhD, Mélanie MD, Sylvie MD, Georges-Philippe MD, PhD, Olivier MD, Jérôme MD, PhD,